| Fignar Family Practice, Llc | |
|
15 Palomba Dr Suite 5 Enfield CT 06082-3888 | |
| (860) 745-1623 | |
| (860) 741-3618 |
| Full Name | Fignar Family Practice, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 15 Palomba Dr, Enfield, Connecticut |
| Authorized Official Name and Position | Timothy Alan Fignar (OWNER) |
| Authorized Official Contact | 8607451623 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Fignar Family Practice, Llc 15 Palomba Dr Suite 5 Enfield CT 06082-3888 Ph: (860) 745-1623 | Fignar Family Practice, Llc 15 Palomba Dr Suite 5 Enfield CT 06082-3888 Ph: (860) 745-1623 |
| NPI Number | 1447433677 |
|---|---|
| Provider Enumeration Date | 12/11/2007 |
| Last Update Date | 05/02/2008 |
| Medicare PECOS PAC ID | 2769560184 |
|---|---|
| Medicare Enrollment ID | O20080424000501 |
News Archive
The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory's testing menu.
Roll Call: "The White House is aggressively courting the small-business community, believing that some on GOP-friendly Main Street can be enlisted in the fight for health care reform and that assistance to mom-and-pop shops is vital to chipping away at the unemployment rate. ... White House officials were on the phone to the [U.S. Chamber of Commerce] and the GOP-leaning National Federation of Independent Business on Friday asking them to provide a group of small-business owners for Obama to talk with at the White House on Thursday."
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
A team of researchers from Penn State University and the University of Chicago has uncovered clues that may explain how and why a particular virus, called N4, injects an unusual substance - an RNA polymerase protein - into an E. coli bacterial cell.
A key feature of Alzheimer's disease is memory loss and losing one's ability to think and make decisions (also called "cognitive ability"). Those changes can begin slowly, during a phase called "mild cognitive impairment" (or MCI). A variety of diseases can cause MCI, but the most common is Alzheimer's disease.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447433677 | NPI | - | NPPES |
| Provider Name | Timothy A Fignar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1396766440 PECOS PAC ID: 1951489376 Enrollment ID: I20080424000494 |
News Archive
The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory's testing menu.
Roll Call: "The White House is aggressively courting the small-business community, believing that some on GOP-friendly Main Street can be enlisted in the fight for health care reform and that assistance to mom-and-pop shops is vital to chipping away at the unemployment rate. ... White House officials were on the phone to the [U.S. Chamber of Commerce] and the GOP-leaning National Federation of Independent Business on Friday asking them to provide a group of small-business owners for Obama to talk with at the White House on Thursday."
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
A team of researchers from Penn State University and the University of Chicago has uncovered clues that may explain how and why a particular virus, called N4, injects an unusual substance - an RNA polymerase protein - into an E. coli bacterial cell.
A key feature of Alzheimer's disease is memory loss and losing one's ability to think and make decisions (also called "cognitive ability"). Those changes can begin slowly, during a phase called "mild cognitive impairment" (or MCI). A variety of diseases can cause MCI, but the most common is Alzheimer's disease.
› Verified 6 days ago
| Provider Name | Carli R Willard |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972935211 PECOS PAC ID: 1456587468 Enrollment ID: I20131122000031 |
News Archive
The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory's testing menu.
Roll Call: "The White House is aggressively courting the small-business community, believing that some on GOP-friendly Main Street can be enlisted in the fight for health care reform and that assistance to mom-and-pop shops is vital to chipping away at the unemployment rate. ... White House officials were on the phone to the [U.S. Chamber of Commerce] and the GOP-leaning National Federation of Independent Business on Friday asking them to provide a group of small-business owners for Obama to talk with at the White House on Thursday."
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
A team of researchers from Penn State University and the University of Chicago has uncovered clues that may explain how and why a particular virus, called N4, injects an unusual substance - an RNA polymerase protein - into an E. coli bacterial cell.
A key feature of Alzheimer's disease is memory loss and losing one's ability to think and make decisions (also called "cognitive ability"). Those changes can begin slowly, during a phase called "mild cognitive impairment" (or MCI). A variety of diseases can cause MCI, but the most common is Alzheimer's disease.
› Verified 6 days ago
News Archive
The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory's testing menu.
Roll Call: "The White House is aggressively courting the small-business community, believing that some on GOP-friendly Main Street can be enlisted in the fight for health care reform and that assistance to mom-and-pop shops is vital to chipping away at the unemployment rate. ... White House officials were on the phone to the [U.S. Chamber of Commerce] and the GOP-leaning National Federation of Independent Business on Friday asking them to provide a group of small-business owners for Obama to talk with at the White House on Thursday."
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.
A team of researchers from Penn State University and the University of Chicago has uncovered clues that may explain how and why a particular virus, called N4, injects an unusual substance - an RNA polymerase protein - into an E. coli bacterial cell.
A key feature of Alzheimer's disease is memory loss and losing one's ability to think and make decisions (also called "cognitive ability"). Those changes can begin slowly, during a phase called "mild cognitive impairment" (or MCI). A variety of diseases can cause MCI, but the most common is Alzheimer's disease.
› Verified 6 days ago
Interanal Medicine And Pediatric Associates Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15 Palomba Dr, Suite 13, Enfield, CT 06082 Phone: 860-749-2251 Fax: 860-745-7747 | |
Alliance In Internal Medicine, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 139 Hazard Ave Ste 2, Enfield, CT 06082 Phone: 860-253-0037 | |
Community Health Resources, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 153 Hazard Ave, Enfield, CT 06082 Phone: 860-253-5020 Fax: 860-253-5030 | |
Darshan J Shah Md Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 139 Hazard Ave Bldg 4, Enfield, CT 06082 Phone: 860-763-0208 | |
Monarch Metabolic And Hormonal Health, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 146 Hazard Ave Ste 107, Enfield, CT 06082 Phone: 860-386-5167 Fax: 860-962-4005 | |
New England Primary Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 55 Hazard Ave, Enfield, CT 06082 Phone: 860-745-9911 |